Disposable cassette for DNA and protein electrophoresis.
DNA and protein detection kits for the research, diagnostics,
forensic and education markets.
Employees: 40
Overview
Founded in 1993 as a bio-discovery company by Dr. Shmulik Cabilly
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
and Mr. Uri Yogev, ETHROG BIOTECHNOLOGIES LTD. has developed
several genetic applications before focusing on its first
commercial invention, the bufferless DNA electrophoresis system
E-Gel, in 1996. Following an exclusive distribution agreement
with Invitrogen Corp., the company established its Tel-Hai
production plant in Northern Israel, from where the first
products were manufactured in 1998.
The company was acquired by Invitrogen in a stock-swap deal in
2000. Since then, ETHROG has developed the next generation of
high-throughput agarose electrophoresis (E-Gel 96 and E-Gel 48),
and launched the E-PAGE protein separation products, based on the
same concept.
ETHROG's research projects are divided into next-generation
separation technology, including the electrophoresis products
E-Gel and E-PAGE, and additional, undisclosed projects, which are
poised to solve other pressing research issues. Within its R&D
department, ETHROG also conducts research on behalf of the
Invitrogen corporate core research laboratory, advancing new and
exciting fields contributing to both drug discovery and basic
research.
ETHROG has issued patents on the core technology of the E-Gel and
E-PAGE, as well as the unique design of the 96-well format
cassette.
ETHROG is actively seeking new projects and applications that may
result in successful products for the bioresearch market. Such
projects are either developed in-house or licensed from Israel's
most innovative academic and biotech institutions.
ETHROG maintains its 12-year commitment to develop advanced,
ground-breaking products that enhance and accelerate life science
research and discovery.
ETHROG employs 40 dedicated workers, who are distributed between
the production plant in Tel-Hai and the company's headquarters
and R&D Center in Ness Ziona, both in Israel.
